BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18667806)

  • 41. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
    Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
    J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.
    Sevin C; Aubourg P; Cartier N
    J Inherit Metab Dis; 2007 Apr; 30(2):175-83. PubMed ID: 17347913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide.
    Bekri S; Bley A; Brown HA; Chanson C; Church HJ; Gelb MH; Hong X; Janzen N; Kasper DC; Mechtler T; Morton G; Murko S; Oliva P; Tebani A; Wu THY
    Mol Genet Metab; 2024 May; 142(1):108436. PubMed ID: 38552449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy
    St Martin T; Seabrook TA; Gall K; Newman J; Avila N; Hayes A; Kivaa M; Lotterhand J; Mercaldi M; Patel K; Rivas IJ; Woodcock S; Wright TL; Seymour AB; Francone OL; Gingras J
    J Neurosci; 2023 May; 43(19):3567-3581. PubMed ID: 36977578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Metachromatic leucodystrophy. Clinical, biological, and therapeutic aspects].
    Barboura I; Ferchichi S; Dandana A; Jaidane Z; Ben Khelifa S; Chahed H; Ben Mansour R; Chebel S; Maire I; Miled A
    Ann Biol Clin (Paris); 2010; 68(4):385-91. PubMed ID: 20650733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telencephalic histopathology and changes in behavioural and neural plasticity in a murine model for metachromatic leukodystrophy.
    Faldini E; Stroobants S; Lüllmann-Rauch R; Eckhardt M; Gieselmann V; Balschun D; D'Hooge R
    Behav Brain Res; 2011 Sep; 222(2):309-14. PubMed ID: 21459117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy.
    Yaghootfam C; Sylvester M; Turk B; Gieselmann V; Matzner U
    Mol Ther; 2023 Oct; 31(10):2962-2974. PubMed ID: 37644722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
    Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
    Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urine sulfatides and the diagnosis of metachromatic leukodystrophy.
    Natowicz MR; Prence EM; Chaturvedi P; Newburg DS
    Clin Chem; 1996 Feb; 42(2):232-8. PubMed ID: 8595716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy.
    Eckhardt M; Hedayati KK; Pitsch J; Lüllmann-Rauch R; Beck H; Fewou SN; Gieselmann V
    J Neurosci; 2007 Aug; 27(34):9009-21. PubMed ID: 17715338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.
    Biffi A; Montini E; Lorioli L; Cesani M; Fumagalli F; Plati T; Baldoli C; Martino S; Calabria A; Canale S; Benedicenti F; Vallanti G; Biasco L; Leo S; Kabbara N; Zanetti G; Rizzo WB; Mehta NA; Cicalese MP; Casiraghi M; Boelens JJ; Del Carro U; Dow DJ; Schmidt M; Assanelli A; Neduva V; Di Serio C; Stupka E; Gardner J; von Kalle C; Bordignon C; Ciceri F; Rovelli A; Roncarolo MG; Aiuti A; Sessa M; Naldini L
    Science; 2013 Aug; 341(6148):1233158. PubMed ID: 23845948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
    Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
    J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy.
    Olkhovich NV; Takamura N; Pichkur NA; Gorovenko NG; Aoyagi K; Yamashita S
    Mol Genet Metab; 2003 Nov; 80(3):360-3. PubMed ID: 14680985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement: a new mutation in the ARSA gene.
    Marcão AM; Wiest R; Schindler K; Wiesmann U; Weis J; Schroth G; Miranda MC; Sturzenegger M; Gieselmann V
    Arch Neurol; 2005 Feb; 62(2):309-13. PubMed ID: 15710861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical, Biochemical, and Molecular Characterization of Metachromatic Leukodystrophy Among Egyptian Pediatric Patients: Expansion of the ARSA Mutational Spectrum.
    Amr K; Fateen E; Mansour L; Tosson AM; Zaki MS; Salam GMA; Mohamed AN; El-Bassyouni HT
    J Mol Neurosci; 2021 May; 71(5):1112-1130. PubMed ID: 33185815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metachromatic Leukodystrophy (MLD): a Pakistani Family with Novel ARSA Gene Mutation.
    Shahzad MA; Khaliq S; Amar A; Mahmood S
    J Mol Neurosci; 2017 Sep; 63(1):84-90. PubMed ID: 28799099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
    Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
    Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.
    Saravanan K; Schaeren-Wiemers N; Klein D; Sandhoff R; Schwarz A; Yaghootfam A; Gieselmann V; Franken S
    Neurobiol Dis; 2004 Jul; 16(2):396-406. PubMed ID: 15193296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.
    Franken S; Wittke D; Mansson JE; D'Hooge R; De Deyn PP; Lüllmann-Rauch R; Matzner U; Gieselmann V
    Lipids Health Dis; 2006 Aug; 5():21. PubMed ID: 16893448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients.
    Beerepoot S; van Dooren SJM; Salomons GS; Boelens JJ; Jacobs EH; van der Knaap MS; van Kuilenburg ABP; Wolf NI
    Neurogenetics; 2020 Oct; 21(4):289-299. PubMed ID: 32632536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.